This clinical trial evaluates whether acupuncture can improve chronic musculoskeletal pain in diverse underserved cancer survivors. Cancer survivors represent one of the largest and fastest growing populations in the United States. Over a third of cancer survivors are inadequately treated for pain which correlates with worse quality of life, physical functioning, and other health-related outcomes. Previous studies with acupuncture have shown the effectiveness of acupuncture on pain management in cancer survivors. However, these studies did not include many non-white and/or Hispanic patients. Non-white or Hispanic survivors are not only under-treated for their pain but also have higher mortality (death) from cancer. Acupuncture has also been shown to be less available in community-based centers, where many patients receive their care. Acupuncture is a medical technique that involves insertion of very thin needles into specific areas on the body with the goal of promoting health and well-being. It has been widely used to treat different types of pain, but researchers think acupuncture can also improve chronic musculoskeletal pain in diverse cancer survivors. Acupuncture may be effective in improving chronic musculoskeletal pain in diverse underserved cancer survivors.
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT06814977.
Locations matching your search criteria
United States
New York
Jamaica
Jamaica HospitalStatus: Active
Contact: Rosa Nouvini
Phone: 718-206-6000
New York
Memorial Sloan Kettering Cancer CenterStatus: Active
Contact: Kevin Liou
Phone: 646-608-8558
PRIMARY OBJECTIVES:
I. To determine the feasibility of studying an acupuncture intervention for chronic musculoskeletal pain in racially/ethnically diverse, community-based cancer survivors.
II. To evaluate implementation outcomes related to acupuncture care delivery in diverse, community-based, under-resourced settings.
III. To explore changes in pain and co-morbid symptoms (sleep disturbance, fatigue, anxiety, depression, and cognitive dysfunction) from baseline through week 14 among the acupuncture group and the usual care control group.
OUTLINE: Patients are randomized to 1 of 2 groups.
GROUP I: Patients receive acupuncture sessions over 20-30 minutes once a week (QW) for 10 weeks on study. Patients may also participate in an optional interview on study.
GROUP II: Patients receive standard medical care, including pain medications and other treatments on study. Patients receive vouchers to receive acupuncture sessions for up to 10 weeks upon study completion.
After completion of study intervention, patients are followed up at 14 weeks.
Trial PhaseNo phase specified
Trial Typesupportive care
Lead OrganizationMemorial Sloan Kettering Cancer Center
Principal InvestigatorKevin Liou
